MedTrace Logo

Gocheck Kids vs. Welch Allyn Spot Vision Screener

NCT04321538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2023-03-01

No results posted yet for this study

Summary

The investigators are conducting a prospective evaluation of the ability of two vision photoscreening devices (GoCheck Kids and the Welch Allyn Spot Vision Screener) to detect risk factors for amblyopia. Photoscreeners function similar to having a picture taken with a camera. Amblyopia is decreased vision in one or both eyes due to decreased vision development in the brain resulting from decreased visual stimulation. Children ages 1 year to less than 7 years of age referred to a pediatric ophthalmologist at Yale New Haven Health and Yale Medicine locations for a failed vision screen will be offered participation. The ability of each screening device to detect amblyopia risk factors will be compared with the results of a complete eye exam performed by the practitioner.

Conditions

  • Amblyopia

Interventions

DEVICE

Gocheck Kids

GoCheck Kids is a photoscreening device. It takes a special picture of the eyes that allows for detection of refractive error and eye misalignment.

DEVICE

Welch Allyn Spot Vision Screener

The Welch Allyn Spot Vision Screener is a photoscreening device. It takes a special picture of the eyes that allows for the detection of refractive error and eye misalignment.

DIAGNOSTIC_TEST

Physical Exam

Retinoscopy and an oculomotor testing will constitute the physical examination.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Martha A Howard, MD · Yale University

Eligibility

Min Age
1 Year
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04321538 on ClinicalTrials.gov